Cargando…

The down-regulation of GNAO1 and its promoting role in hepatocellular carcinoma

GNAO1 (guanine nucleotide-binding protein, α-activating activity polypeptide O) is a member of the subunit family of Gα proteins, which are molecular switchers controlling signal transductions and whose deregulation can promote oncogenesis. HCC (hepatocellular carcinoma) is one of the malignant tumo...

Descripción completa

Detalles Bibliográficos
Autores principales:	Pei, Xiaoyu, Zhang, Jun, Wu, Lijun, Lü, Bin, Zhang, Xiaojiao, Yang, Dongqin, Liu, Jie
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Portland Press Ltd. 2013
Materias:	Original Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3775511/ https://www.ncbi.nlm.nih.gov/pubmed/23984917 http://dx.doi.org/10.1042/BSR20130001

Ejemplares similares

GNAO1 as a Novel Predictive Biomarker for Late Relapse in Hepatocellular Carcinoma
por: Du, Meiling, et al.
Publicado: (2021)

Phenotypes of GNAO1 Variants in a Chinese Cohort
por: Yang, Xiaoling, et al.
Publicado: (2021)

Highlighting the Dystonic Phenotype Related to GNAO1
por: Wirth, Thomas, et al.
Publicado: (2022)

Phenotypes in children with GNAO1 encephalopathy in China
por: Li, Yanmei, et al.
Publicado: (2023)

Visual Function in Children with GNAO1-Related Encephalopathy
por: Gambardella, Maria Luigia, et al.
Publicado: (2023)

GNAO1 encephalopathy: Broadening the phenotype and evaluating treatment and outcome
por: Danti, Federica Rachele, et al.
Publicado: (2017)

Down-Regulated CMTM2 Promotes Epithelial-Mesenchymal Transition in Hepatocellular Carcinoma
por: Zhang, Shidong, et al.
Publicado: (2020)

GNAO1-related neurodevelopmental disorder: Literature review and caregiver survey
por: JoJo Yang, Qian-Zhou, et al.
Publicado: (2022)

Humanization of Drosophila Gαo to Model GNAO1 Paediatric Encephalopathies
por: Savitsky, Mikhail, et al.
Publicado: (2020)

Cognitive Assessment in GNAO1 Neurodevelopmental Disorder Using an Eye Tracking System
por: Graziola, Federica, et al.
Publicado: (2021)

Dystonic Cerebral Palsy Phenotype Due to GNAO1 Variant Responsive to Levodopa
por: Vasconcellos, Luiz Felipe, et al.
Publicado: (2023)

Pediatric GNAO1 encephalopathies: from molecular etiology of the disease to drug discovery
por: Katanaev, Vladimir L., et al.
Publicado: (2023)

Possible Down Regulation of the p16 Gene Promoter in Individuals with Hepatocellular Carcinoma
por: Shiraz, Oranous Bashti, et al.
Publicado: (2011)

WT1-AS promotes cell apoptosis in hepatocellular carcinoma through down-regulating of WT1
por: Lv, Long, et al.
Publicado: (2015)

Icaritin promotes apoptosis and inhibits proliferation by down-regulating AFP gene expression in hepatocellular carcinoma
por: Li, Hui, et al.
Publicado: (2021)

Identification of a Novel Gnao-Mediated Alternate Olfactory Signaling Pathway in Murine OSNs
por: Scholz, Paul, et al.
Publicado: (2016)

GNAO1 encephalopathy: further delineation of a severe neurodevelopmental syndrome affecting females
por: Marcé-Grau, Anna, et al.
Publicado: (2016)

Gαo (GNAO1) encephalopathies: plasma membrane vs. Golgi functions
por: Solis, Gonzalo P., et al.
Publicado: (2017)

Clinical Phenotype of De Novo GNAO1 Mutation: Case Report and Review of Literature
por: Talvik, Inga, et al.
Publicado: (2015)

Spectrum of movement disorders in GNAO1 encephalopathy: in-depth phenotyping and case-by-case analysis
por: Kim, Soo Yeon, et al.
Publicado: (2020)

Genetic modeling of GNAO1 disorder delineates mechanisms of Gαo dysfunction
por: Wang, Dandan, et al.
Publicado: (2021)

Deep brain stimulation in a young child with GNAO1 mutation – Feasible and helpful
por: Fung, Eva Lai-wah, et al.
Publicado: (2022)

Clinical significance of down-regulated HINT2 in hepatocellular carcinoma
por: Zhou, Dong-Kai, et al.
Publicado: (2019)

Gain-of-function mutation in Gnao1: A murine model of epileptiform encephalopathy (EIEE17)?
por: Kehrl, Jason M., et al.
Publicado: (2014)

Mouse models of GNAO1-associated movement disorder: Allele- and sex-specific differences in phenotypes
por: Feng, Huijie, et al.
Publicado: (2019)

Gonadal mosaicism in GNAO1 causing neurodevelopmental disorder with involuntary movements; two additional variants
por: Al Masseri, Zainab, et al.
Publicado: (2022)

Treating GNAO1 mutation-related severe movement disorders with oxcarbazepine: a case report
por: Ling, Weihao, et al.
Publicado: (2022)

Phenotypic Assessment of Pathogenic Variants in GNAO1 and Response to Caffeine in C. elegans Models of the Disease
por: Di Rocco, Martina, et al.
Publicado: (2023)

GNAO1-related Neurodevelopmental Disorder Presenting as Acute Encephalitis Syndrome: A Phenotypic Expansion
por: Panda, Prateek Kumar, et al.
Publicado: (2023)

Role of 15-hydroxyprostaglandin dehydrogenase down-regulation on the prognosis of hepatocellular carcinoma
por: Yang, Jee Eun, et al.
Publicado: (2014)

An integrated analysis of SOCS1 down-regulation in HBV infection-related hepatocellular carcinoma
por: Zhang, X, et al.
Publicado: (2014)

Allele Loss and Down-Regulation of Heparanase Gene Are Associated with the Progression and Poor Prognosis of Hepatocellular Carcinoma
por: Huang, Guo-Liang, et al.
Publicado: (2012)

Pediatric Encephalopathy: Clinical, Biochemical and Cellular Insights into the Role of Gln52 of GNAO1 and GNAI1 for the Dominant Disease
por: Solis, Gonzalo P., et al.
Publicado: (2021)

Both subthalamic and pallidal deep brain stimulation are effective for GNAO1-associated dystonia: three case reports and a literature review
por: Liu, Ye, et al.
Publicado: (2022)

Retraction: Mouse models of GNAO1-associated movement disorder: Allele- and sex-specific differences in phenotypes
por: Feng, Huijie, et al.
Publicado: (2021)

DBS emergency surgery for treatment of dystonic storm associated with rhabdomyolysis and acute colitis in DYT-GNAO1
por: Chaib, Hind, et al.
Publicado: (2022)

Down-regulated of PCDH10 predicts poor prognosis in hepatocellular carcinoma patients
por: Bing, Yuntao, et al.
Publicado: (2018)

Down-regulation of β-arrestin2 promotes tumour invasion and indicates poor prognosis of hepatocellular carcinoma
por: Sun, Wu-Yi, et al.
Publicado: (2016)

Exosome‐transmitted circ_MMP2 promotes hepatocellular carcinoma metastasis by upregulating MMP2
por: Liu, Dengrui, et al.
Publicado: (2020)

Baicalein Inhibits the Invasion and Metastatic Capabilities of Hepatocellular Carcinoma Cells via Down-Regulation of the ERK Pathway
por: Chen, Kunlun, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_e2v92j9efa6ujf3nh8nid9f0gk